This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richardson, B. E. Articles by Wormuth, J. K. Search for Related Content PubMed PubMed Citation Articles by Richardson, B. E. Articles by Wormuth, J. K.

Mean Arterial Pressure, Pregnancy-induced Hypertension, and Preeclampsia: Evaluation as Independent Risk Factors and as Surrogates for High Maternal Serum -Fetoprotein in Estimating Breast Cancer Risk¹

Department of Epidemiology and Biostatistics, School of Rural Public Health, Texas A&M University System Health Science Center, College Station, Texas 77843-1266 [B. E. R.]; Department of Epidemiology, University of North Carolina at Chapel Hill, School of Public Health, Chapel Hill, North Carolina 27599-7400 [J. D. P.]; and School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 [J. K. W.]

Data from a nested case-control study were analyzed to examine high mean arterial pressure (MAP), hypertension of pregnancy, and preeclampsia as independent predictors and as surrogate markers for elevated -fetoprotein (AFP) levels in evaluating breast cancer risk. Cases (n = 205) were identified by the California Cancer Registry from a cohort of pregnant women who were part of the Kaiser Health Plan and took part in the Child Health and Development Studies initiated by the University of California, Berkeley, from June 1959 to September 1966. Controls (n = 337) were selected by randomized recruitment from the same cohort probability matched to cases by distribution of birth dates of cases. High MAP was associated with breast cancer risk and is different across quartile of age at first full-term pregnancy as is high AFP. Odds ratios (OR) across quartiles for MAP were 0.24 [95% confidence interval (CI), 0.08–0.71], 0.84 (95% CI, 0.39–1.66), 1.00 (referent), and 2.50 (95% CI, 1.21–5.13), and for AFP were 0.34 (95% CI, 0.13–0.93), 0.77 (95% CI, 0.36–1.67), 1.00 (referent), and 2.38 (95% CI, 1.13–5.00). Neither diagnosed preeclampsia nor hypertension of pregnancy showed any association with breast cancer risk. When both high AFP and high MAP were entered into the same analysis, neither changed the OR for the other more than 8%. Additionally, AFP level was not a linear function of MAP. Although the pattern of ORs across quartiles of age at first full-term pregnancy was similar for the two variables, it cannot be concluded that high MAP is an adequate surrogate for high levels of maternal serum AFP, but rather represents some related process that is in and of itself a risk factor for breast cancer.

This article has been cited by other articles:

				R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF]

				R. Troisi, L. Vatten, R. N. Hoover, J. M. Roberts, B. F. Cole, and N. Potischman Maternal androgen and estrogen concentrations are not associated with blood pressure changes in uncomplicated pregnancies. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 2013 - 2015. [Abstract] [Full Text] [PDF]

				S. de Assis, M. Wang, S. Goel, A. Foxworth, W. Helferich, and L. Hilakivi-Clarke Excessive Weight Gain during Pregnancy Increases Carcinogen-Induced Mammary Tumorigenesis in Sprague-Dawley and Lean and Obese Zucker Rats J. Nutr., April 1, 2006; 136(4): 998 - 1004. [Abstract] [Full Text] [PDF]

				B. A. Cohn, P. M. Cirillo, R. E. Christianson, B. J. van den Berg, and P. K. Siiteri Placental Characteristics and Reduced Risk of Maternal Breast Cancer J Natl Cancer Inst, August 1, 2001; 93(15): 1133 - 1140. [Abstract] [Full Text] [PDF]